Ascletis Pharma (OTCMKTS:ASCLF) Stock Price Down 16.5% – What’s Next?

Ascletis Pharma Inc. (OTCMKTS:ASCLF)’s share price fell 16.5% during trading on Monday . The company traded as low as $0.18 and last traded at $0.18. 3,000 shares changed hands during trading, a decline of 69% from the average session volume of 9,560 shares. The stock had previously closed at $0.21.

Ascletis Pharma Stock Performance

The business has a 50 day moving average of $0.17 and a 200 day moving average of $0.16.

About Ascletis Pharma

Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.